The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Diana Luna Buitrago und 21 weiteren Autor:innen. Beteiligte Einrichtung: University/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edi…. Hauptthemen laut MEDLINE: MicroRNAs, Vascular Calcification, Aorta, Muscle, Smooth, Vascular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Scotland PhD studentship, BHF Clinical Research Training Fellowship, Edinburgh Scientific Academic Track.
Abstract (Originalsprache)
Aims
Vascular calcification is the abnormal deposition of calcium phosphates within blood vessels. This condition is significantly associated with the development of cardiovascular disease, yet the underlying mechanisms remain largely unknown. MicroRNAs (miRNAs) may be crucial in initiating vascular calcification by regulating a network of specific cellular targets. In this study, we explored for the first time the potential role of microRNA-26b (miR-26b) in vascular calcification. Methods and results Using micro-positron emission tomography and computed tomography (micro-PET/CT) imaging with 18F–sodium fluoride, we measured aortic calcification in miR-26b knockout mice (miR-26bKO). We conducted bulk RNA sequencing (RNA-seq), single-cell RNA sequencing, and network analysis to identify cell-specific targets and the cellular complexity contributing to the observed phenotype. Additionally, we examined aortic tissues from patients with aortic aneurysm or valvular-related aortopathy to determine how the expression levels of miR-26b and its targets correlate with calcification. Our findings revealed that miR-26b is downregulated in the aortic tissues of patients with aortic calcification, whereas miR-26b expression negatively correlates with calcification levels. Similarly, miR-26bKO mice developed spontaneous age-related aortic microcalcifications. Combining single-cell transcriptomics with network analyses, we identified and mapped cell-type specific targets of miR-26b and regulatory pathways. Furthermore, we validated the cell-specific expression of Smad1 in smooth muscle cells (SMCs) and characterized the cell–cell communication between aortic cells, exposing the bone morphogenetic protein (BMP) pathway. The development of microcalcification was attributed to Bmp4 released from fibroblasts (FBLs), leading to Smad1 phosphorylation and calcium accumulation in SMCs of miR-26bKO mice. We found that aortic microcalcification could be pharmacologically reversed by disrupting cellular communication. Lastly, we demonstrated an inverse correlation between miR-26b and SMAD1 levels in calcified aortic tissues.
Conclusion
The deficiency of miR-26b is crucial for initiating and promoting aortic calcification, revealing new therapeutic targets for aortic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
- Cardiovascular Translational Research, Navarrabiomed (Fundación Miguel Servet), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), P…
- School of Engineering, King's Buildings, The University of Edinburgh, Edinburgh, UK.
- MRC Human Genetics Unit, MRC Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
- School of Cardiovascular and Metabolic Health, BHF Centre of Research Excellence, The University of Glasgow, Glasgow, UK.
- School of Infection and Immunity, College of Medical Veterinary and Life Sciences, The University of Glasgow, Glasgow, UK.
ORCID-Profile: Ryszard Nosalski, Tijana Mitić, Andrea Caporali
Förderung
- Medical Research Scotland PhD studentship
- BHF Clinical Research Training Fellowship
- Edinburgh Scientific Academic Track
- REA3 Institutional Award
- AtheroNET COST Action
- EU-COST
- European Cooperation in Science and Technology
- British Heart Foundation
Zitieren
APA
Luna Buitrago, D., Jover, E., Mameli, E., Mellis, D., Nosalski, R., Charlton, L., Bauza Sanso, R., Dunn-Davies, H., MacAskill, M. G., Tavares, A. A. S., Fletcher, A. J., Nash, J., López-Andrés, N., Dweck, M. R., Hadoke, P. W. F., Gilchrist, D. S., Wagner, B. D., Robinson, M. L., Baker, A. H., …, & Caporali, A. (2025). The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf117
Vancouver
Luna Buitrago D, Jover E, Mameli E, Mellis D, Nosalski R, Charlton L, et al. The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf117
BibTeX
@article{LunaBuitrago2025,
author = {Luna Buitrago, Diana and Jover, Eva and Mameli, Eleonora and Mellis, David and Nosalski, Ryszard and Charlton, Laura and Bauza Sanso, Rosa and Dunn-Davies, Hywel and MacAskill, Mark G and Tavares, Adriana A S and Fletcher, Alexander J and Nash, Jennifer and López-Andrés, Natalia and Dweck, Marc R and Hadoke, Patrick W F and Gilchrist, Derek S and Wagner, Brad D and Robinson, Michael L and Baker, Andrew H and Newby, David E and Mitić, Tijana and Caporali, Andrea},
title = {The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf117}
}
EUVIMED